Allurion Technologies Inc
ALUR
查看详细走势图
1.405USD
-0.095-6.33%
收盘 12/19, 16:00（美东）报价延迟15分钟
10.91M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-6.33%
5天
-15.87%
1月
+11.51%
6月
-39.44%
今年开始到现在
-86.93%
1年
-83.85%
查看详细走势图
TradingKey Allurion Technologies Inc股票评分
单位: USD 更新时间: 2025-12-19操作建议
Allurion Technologies Inc当前公司基本面数据相对健康，增长潜力稳定。当前估值合理，在软件与IT服务行业排名193/482位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价5.50。中期看，股价处于下降通道。近一个月，市场表现很强，技术面评分较高，但很强的走势得没有得到基本面的印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
Allurion Technologies Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
3
位分析师
买入
评级
5.500
目标均价
+227.38%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Allurion Technologies Inc亮点
亮点风险
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
业绩增长期
公司处于发展阶段，最新年度总收入32.11M美元
估值高估
公司最新PE估值-0.01，处于3年历史高位
机构加仓
最新机构持股6.53M股，环比增加33.90%
先锋集团持仓
明星投资者先锋集团持仓，最新持仓市值56.18K
Allurion Technologies Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Allurion Technologies Inc简介
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
公司代码ALUR
公司Allurion Technologies Inc
CEOGaur (Shantanu)
网址https://www.allurion.com/en
常见问题
Allurion Technologies Inc(ALUR)的当前股价是多少？
Allurion Technologies Inc(ALUR)的当前股价是 1.405。
Allurion Technologies Inc的股票代码是什么？
Allurion Technologies Inc的股票代码是ALUR。
Allurion Technologies Inc股票的52周最高点是多少？
Allurion Technologies Inc股票的52周最高点是16.810。
Allurion Technologies Inc股票的52周最低点是多少？
Allurion Technologies Inc股票的52周最低点是1.020。
Allurion Technologies Inc的市值是多少？
Allurion Technologies Inc的市值是10.91M。
Allurion Technologies Inc的净利润是多少？
Allurion Technologies Inc的净利润为-26.15M。
现在Allurion Technologies Inc(ALUR)的股票是买入、持有还是卖出？
根据分析师评级，Allurion Technologies Inc(ALUR)的总体评级为买入，目标价格为5.500。
Allurion Technologies Inc(ALUR)股票的每股收益（EPS TTM）是多少
Allurion Technologies Inc(ALUR)股票的每股收益（EPS TTM）是-295.460。
相关品种
